Pioneering Cellular Immunotherapies for Cancer and Auto Immune Disorders

At Immunex Shield, we harness the power of your immune system to combat cancer and immune disorders through cutting-edge cellular therapies. 

Our NextGen Cellular Therapies

Natural Killer (NK) Cell Therapy

About

Natural killer cell - Wikipedia

Natural Killer cells are your body’s first line of defense against cancer and viral infections. Our proprietary NK cell enhancement technology amplifies these powerful immune warriors to recognize and eliminate cancer cells with unprecedented efficiency.

How NK Cell Therapy Works:

  1. We extract NK cells from your blood or from healthy donors
  2. Our proprietary activation process enhances the cells’ cancer-fighting abilities
  3. The supercharged NK cells are expanded to therapeutic quantities
  4. These enhanced cells are infused back into your body to seek and destroy cancer cells

Our NK cell therapy has shown remarkable results in treating:

  • Hematological malignancies
  • Solid tumors
  • Treatment-resistant cancers
Dendritic Cell Therapy

About

Dendritic cell, SEM - Stock Image - F022/5749 - Science Photo Library

Dendritic cells are the immune system’s most powerful antigen-presenting cells, essentially teaching your body which cells to attack. Our dendritic cell therapy creates a personalized cancer vaccine using your own immune cells.

The ImmuneX Shield Dendritic Cell Process:

  1. We collect a sample of your blood to isolate immature dendritic cells
  2. These cells are exposed to your specific cancer antigens in our laboratory
  3. The now-educated dendritic cells are activated and multiplied
  4. When reintroduced to your body, they train your T cells to recognize and destroy your specific cancer cells

Dendritic cell therapy is particularly effective for:

  • Melanoma
  • Prostate cancer
  • Glioblastoma
  • Other solid tumors with identifiable antigens
T Cell Therapy

About

T cell immunity: What is it and how does it help to protect us from COVID-19? | Imperial News | Imperial College London

T cells are the adaptive immune system’s primary soldiers. Our T cell therapies include both CAR-T (Chimeric Antigen Receptor T cell) and TCR (T Cell Receptor) approaches to reprogram your immune system for targeted cancer elimination.

Our Advanced T Cell Platforms:

1. CAR-T Cell Therapy

  • We engineer your T cells to express receptors that recognize specific cancer markers
  • These modified cells become precision weapons against your cancer
  • Upon reinfusion, they multiply and persist, providing ongoing surveillance

2. TCR Therapy

  • Enhances your T cells’ ability to recognize cancer antigens presented inside cells
  • Particularly effective against solid tumors that evade standard treatments
  • Creates a memory response for long-term protection

T cell therapies have revolutionized treatment for:

  • Leukemias and lymphomas
  • Multiple myeloma
  • Selected solid tumors
B Cell Therapy

About

T cell immunity: What is it and how does it help to protect us from COVID-19? | Imperial News | Imperial College London

B cells are your immune system’s intelligent antibody factories, creating targeted weapons against specific threats like cancer. Our proprietary B cell engineering technology transforms these master cells into elite anti-cancer warriors, arming them to produce potent antibodies that tag and eliminate cancer cells with remarkable precision.

B cell therapy has shown remarkable results in treating:

Hematological malignancies (including B-cell lymphomas and leukemias)
Solid tumors
Cancers that have evaded other therapies

Why Immunex Shield?

Personalized Medicine Approach

Personalized Medicine Approach

Every patient’s immune system and disease are unique. Our therapies are customized based on:

  • Patient specific Tumour antigens, immunogenetics and disease profile
  • Your immune system’s characteristics
  • Gut Microbiome Epigenetics/Genetics analysis of your disease
No Side Effects

No Side Effects

Unlike traditional cancer treatments that damage healthy immune cells, our immunotherapies work with your body’s natural defenses, resulting in:
  • Reduced systemic toxicity
  • Preservation of healthy tissue
  • Improved quality of life during treatment
Cutting-Edge Research

Cutting-Edge Research

Our team of immunologists, oncologists, and cellular therapy experts continuously advance our platforms through:

  • Proprietary cell activation technologies
  • Novel targeting mechanisms
  • Enhanced cell persistence techniques
  • Combination therapy approaches
ImmunexShield - Orbital Network (Rotating, Light BG)
ImmunexShield
TMB/MSI
T/B cell epitopes & Peptides
PD-L1/CTLA4 Scores
Primary Cancer Cells
Circulating Tumor Cells
Tumor Exosomes
Gut Microbiome
ImmunexShield - Advanced Immunoprofiling

ImmunexShield

Advanced Immunoprofiling Solutions

Tumor Mutation Burden
Microsatellite Instability
PDL1/CTLA Scores
Primary Cancer Cells
Circulating Tumor Cells
Tumor Exosomes
Gut Microbiome

Research and Innovation

Immunex Shield is committed to advancing the field of cellular immunotherapy through:

Next-Generation Platforms

  • Development of off-the-shelf NK cell products
  • Multi-targeted CAR constructs
  • Antigen discovery

Strategic Partnerships

Collaborations with leading academic institutions and biotechnology companies to accelerate breakthrough treatments.

Expanding Indications

Research into applying our cellular therapies to autoimmune disorders, infectious diseases, and age-related immune dysfunction.